Randall Stanicky

Stock Analyst at RBC Capital

(2.49)
# 2,473
Out of 5,045 analysts
31
Total ratings
66.67%
Success rate
8.67%
Average return

Stocks Rated by Randall Stanicky

AbbVie
Feb 4, 2021
Maintains: Outperform
Price Target: $129$135
Current: $225.14
Upside: -40.04%
Perrigo Company
Jan 6, 2021
Downgrades: Sector Perform
Price Target: $59$49
Current: $21.28
Upside: +130.26%
Pfizer
Dec 16, 2020
Downgrades: Sector Perform
Price Target: $43$42
Current: $24.29
Upside: +72.91%
Jazz Pharmaceuticals
Nov 3, 2020
Maintains: Outperform
Price Target: $170$180
Current: $135.73
Upside: +32.62%
Merck & Co.
Apr 1, 2020
Maintains: Sector Perform
Price Target: $92$89
Current: $86.58
Upside: +2.80%
Amneal Pharmaceuticals
Jan 2, 2020
Maintains: Sector Perform
Price Target: $3$4
Current: $10.43
Upside: -61.65%
Teva Pharmaceutical Industries
Aug 4, 2017
Downgrades: Underperform
Price Target: n/a
Current: $20.23
Upside: -
Pacira BioSciences
Apr 13, 2017
Initiates: Outperform
Price Target: $58
Current: $21.01
Upside: +176.06%